Phagocyte Deficiencies
Phagocyte deficiencies include (a)
chronic granulomatous disease, (b)
Chediak–Higashi syndrome, (c) Job’s
syndrome, (d) leukocyte adhesion
deficiency, (e) myeloperoxidase
defi-ciency, and ( f ) cyclic
neutropenia.
Chronic granulomatous disease (CGD) is a disorder that is inherited
as an X-linked trait in two-thirds of the cases and as an autosomal recessive
trait in the remaining one-third. Clinical manifestations are usually apparent
before the end of the 2nd year of life. This is a condition associated with
defi-ciency of an enzyme NADPH oxidase. This enzyme deficiency causes neutrophils
and monocytes to have decreased consump-tion of oxygen and diminished glucose
utilization by the hex-ose monophosphate shunt. Although neutrophils
phagocytose microorganisms, they do not form superoxide and other oxy-gen
intermediates that usually constitute the respiratory burst. All of these lead
to decreased intracellular killing of bacteria and fungi. Thus, these
individuals have an increased suscepti-bility to infection with microorganisms
that normally are of relatively low virulence. These include Aspergillus, Serratia marc-escens, and
Staphylococcus epidermidis.
Patients with CGD may have hepatosplenomegaly, pneu-monia,
osteomyelitis, abscesses, and draining lymph nodes.
The quantitative nitroblue tetrazolium (NBT) test and the
quantitative killing curve are both employed to confirm the diagnosis of CGD.
Therapy includes interferon gamma, antibiotics, and surgical drainage of
abscesses.
It is a childhood disorder with an autosomal recessive mode of
inheritance. The condition is identified by the presence of large lysozomal
granules in leukocytes that are very stable and undergo slow degranulation. The
large cytoplasmic granular inclusions that appear in white blood cells may also
be observed in blood platelets and can be seen by regular light microscopy in
peripheral blood smears. The condition is characterized by a defective
neutrophil chemotaxis and an altered ability of the cells to kill ingested
microorganisms. The majority of affected individuals die during childhood,
although occasional cases may live longer.
There is no effective therapy other than the administration of
antibiotics for treatment of the infecting microorganisms. High doses of
ascorbic acid have been shown to restore normal chemotaxis, bactericidal
activity, and degranulation.
Job’s syndrome is caused by failure of helper T cells to produce
gamma interferon, which in turn reduces the ability of mac-rophages to kill
bacteria. This results in an increased produc-tion of Th-2 and consequently an
increased production of IgE. All these in turn cause more production of
histamine that prevents certain components of inflammatory reaction and also
inhibits chemotaxis. Therefore, the patient with this syndrome suffers
repeatedly from staphylococcal abscesses as well as eczema with a high level of
IgE.
It is an autosomal recessive disease caused by mutation in the gene
encoding the B chain of an integrin that mediates adhesion of leukocytes to
microbes. This causes poor adhe-sion of neutrophils to endothelial surfaces;
hence phagocytosis of bacteria is inadequate.
It is an autosomal dominant disease in which there is a mutation in
the gene encoding neutrophil esterase, an enzyme produced by neutrophils. The
disease is characterized by a very low neutrophil count, less than 200/mL for 3–6 days of a 21-day
cycle. The patients are susceptible to life-threatening bacterial infections
during these 3–6 days of low neutrophil count but not when neutrophil counts
are normal.
It is a disease associated with deficiency of an enzyme
myeloper-oxidase, which is essential for the production of hypochlorite, a
microbicidal agent. The deficiency of this enzyme is fre-quently seen but has
little clinical importance. This is because other intracellular killing
mechanisms of leukocytes are intact.
Related Topics
Privacy Policy, Terms and Conditions, DMCA Policy and Compliant
Copyright © 2018-2023 BrainKart.com; All Rights Reserved. Developed by Therithal info, Chennai.